ENGLEWOOD, Colo., Sept. 05, 2017 -- Gevo, Inc. (NASDAQ:GEVO), today announced it will be participating in the BEI AlphaDirect Virtual Conference Series on Thursday, September 7, 2017 at 11:00 AM MDT/1:00 PM EDT.
Gevo’s Chief Executive Officer, Dr. Patrick Gruber, will present a detailed company overview, including market development efforts and company growth plans, followed by a brief open question and answer session with the investment community. The presentation will be webcast live and made available for replay for sixty days on the company’s website (www.gevo.com) under the Investors section and on the BEI Investor Center page (www.bioeconomyinvestor.com).
“We are glad to be able to connect with the financial community in an open forum accessible to all investors and stakeholders. In addition to providing a general overview, there will be an opportunity for participants to ask questions and we encourage our investors to actively participate as part of the presentation,” said Dr. Gruber.
Investors interested in attending or participating in the virtual conference series must register using the link below. Please note that registration for the live event is limited to the first 300 registrants and is based on a first come first served basis. Questions will be answered based on the allotted time. A webcast replay will be available for sixty days following the live event on Gevo’s and the BEI Investor Center’s websites and can be accessed and replayed at any time. To register, please visit: https://pgi.webcasts.com/starthere.jsp?ei=1161221&tp_key=2aaa2b9b33
About Gevo
Gevo is a leading renewable technology, chemical products, and next generation biofuels company. Gevo has developed proprietary technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstocks. Gevo’s strategy is to commercialize biobased alternatives to petroleum-based products to allow for the optimization of fermentation facilities’ assets, with the ultimate goal of maximizing cash flows from the operation of those assets. Gevo produces isobutanol, ethanol and high-value animal feed at its fermentation plant in Luverne, Minnesota. Gevo has also developed technology to produce hydrocarbon products from renewable alcohols. Gevo currently operates a biorefinery in Silsbee, Texas, in collaboration with South Hampton Resources Inc., to produce renewable jet fuel, octane, and ingredients for plastics like polyester. Gevo has a marquee list of partners including The Coca-Cola Company, Toray Industries Inc. and Total SA, among others. Gevo is committed to a sustainable bio-based economy that meets society’s needs for plentiful food and clean air and water.
About BioEconomy Investor
BioEconomy Investor (BEI) is an independent research and Investor Intelligence firm that creates and implements digital content and programs to help investors better understand a company’s key drivers including industry dynamics, technology, strategy, outlook and risks as well as the impact they could have on the stock price. BioEconomy Investor’s expertise encompasses a variety of sectors including Chemicals and Materials, Fuels, Nutrition, AgTech, Raw Materials, Bioconversion and Manufacturing and Genetics and Genomics. BEI was founded by Wall Street veteran and research analyst, Shawn Severson, after seeing a significant shift in the investment industry that resulted in less fundamental research conducted on small cap companies and a significant decline in information available to all investors. BEI’s mission is to bridge that information gap and engage companies and investors in a way that opens information flow and analytical insights.
Media Contact David Rodewald The David James Agency, LLC +1 805-494-9508 [email protected] Investor Contact Shawn M. Severson BioEconomy Investor +1 415-233-7094 [email protected] @ShawnEnergyTech www.bioeconomyinvestor.com


Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Apple Turns 50: From Garage Startup to AI Crossroads
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 



